NCT04053062View on ClinicalTrials.gov

LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer

PHASE1SuspendedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

May 15, 2022

Study Completion Date

October 15, 2024

Conditions
Castrate-Resistant Prostate Cancer
Interventions
BIOLOGICAL

LIGHT-PSMA-CART cells

LIGHT-PSMA-CART cells will be given IV at split doses

Trial Locations (1)

200433

Changhai Hospital, Shanghai

Sponsors
All Listed Sponsors
collaborator

Changhai Hospital

OTHER

lead

Bioray Laboratories

INDUSTRY

NCT04053062 - LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter